Top Markets
#1 Helium Helium +51.12%
#2 TENDIES TENDIES +40.50%
#3 Pons Pons +28.45%
#4 Seeker Seeker +20.84%
#5 UnifAI Network UnifAI Network +19.25%
#6 Songbird Songbird +12.26%
#7 Lista DAO Lista DAO +11.34%
#8 OSK OSK +10.10%
#9 DAPPOS DAPPOS +9.96%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +9.71%
Coin of the day
Helium Helium
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Aarti Pharmalabs Limited Aarti Pharmalabs Limited

Aarti Pharmalabs Limited

AARTIPHARM
Classifica tra le azioni #10430
Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and... Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.
Prezzo delle azioni
$9.28
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$841.31M
Variazione (1 giorno)
3.34%
Variazione (1 anno)
-2.77%
Paese
IN
Scambia Aarti Pharmalabs Limited (AARTIPHARM)

Categoria

Healthcare
Utile per Aarti Pharmalabs Limited (AARTIPHARM)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Aarti Pharmalabs Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Aarti Pharmalabs Limited dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
$1.76B -
IN